Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery
MP Lisanti, UE Martinez-Outschoorn, F Sotgia - Cell cycle, 2013 - Taylor & Francis
Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and" fibroblast addiction" are new therapeutic targets for drug discovery.
MP Lisanti, UE Martinez-Outschoorn… - Cell Cycle (Georgetown …, 2013 - europepmc.org
Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
[PDF][PDF] Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery
MP Lisanti, UE Martinez-Outschoorn, F Sotgia - cell cycle, 2013 - academia.edu
Metabolic coupling, between mito-chondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
[HTML][HTML] Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery
MP Lisanti, UE Martinez-Outschoorn, F Sotgia - Cell Cycle, 2013 - ncbi.nlm.nih.gov
Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
[引用][C] Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery
MP Lisanti, UE Martinez-Outschoorn, F Sotgia - Cell Cycle, 2013 - cir.nii.ac.jp
Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast
addiction” are new therapeutic targets for drug discovery | CiNii Research CiNii 国立情報学 …
addiction” are new therapeutic targets for drug discovery | CiNii Research CiNii 国立情報学 …
Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and" fibroblast addiction" are new therapeutic targets for drug discovery
MP Lisanti… - Cell cycle …, 2013 - pubmed.ncbi.nlm.nih.gov
Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and" fibroblast addiction" are new therapeutic targets for drug discovery
MP Lisanti, UE Martinez-Outschoorn… - Cell …, 2013 - research.manchester.ac.uk
Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and" fibroblast addiction" are new therapeutic targets for drug discovery.
MP Lisanti, UE Martinez-Outschoorn… - Cell Cycle (Georgetown …, 2013 - europepmc.org
Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …
fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug …